![A photo of Eli Lilly corporate center](https://www.uc.edu/news/articles/2022/05/n21088241/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1652114542591.jpg)
Healthline: What we know about Eli Lilly’s experimental weight-loss drug
UC expert says weight loss often doesn’t last long term
According to drugmaker Eli Lilly, participants in a clinical trial lost over 50 pounds on average when they were treated with the highest dose of a new hunger suppressant.
The drug, called tirzepatide, is making headlines, but has not yet been approved or authorized by the Food and Drug Administration. Additionally, the initial research has been made public by the drug maker Eli Lilly and has not yet been published in a peer-reviewed medical journal.
In a story on the drug published by Healthline, one of the experts quoted is Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine.
Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism at the UC College of Medicine/Photo/Colleen Kelley/UC Creative + Brand
Patel told Healthline that approaches to weight loss have typically involved dieting but that diets often result only in short term weight loss because they are extremely difficult to stick with for an indefinite period of time.
“The reason that all these diets fail is that human beings cannot stick with any one of these diet plans forever,” he said.
Patel points out that due to the complexity of obesity relying on a single solution, whether a diet or a pill, is likely not going to work long term.
“We have yet another weight loss drug to help patients," said Patel. “But drugs by themselves, just like crash diets by themselves, you can see weight loss – but you won’t be successful.”
He said if people with obesity want to lose weight it may require multiple interventions some of which may include medical interventions.
Patel pointed out that even bariatric surgery, which involves shrinking or bypassing the stomach through surgery, requires patients to change their long-term approach to diet and exercise for the best results.
Lead photo/Darron Cummings/AP
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC 1819 Innovation Hub partner takes health care from Cincinnati...
August 30, 2024
Christopher Lewis, founder of the Village Life Outreach Project and a professor of medicine at the University of Cincinnati, strives to boost health outcomes in his hometown and across the world in Tanzania.
How to fend off mosquitoes
![The New York Times logo](/content/dam/refresh/uc-news/news-icons/dark/nyt.png)
August 30, 2024
Mosquitoes can transmit pathogens that cause diseases, including West Nile virus and, in very rare cases, a disease known as Eastern equine encephalitis, or E.E.E. A UC expert spoke to the New York Times about simple precautions to keep mosquitoes away.
Study combines data, molecular simulations to accelerate drug...
August 30, 2024
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital have found a new method to increase both speed and success rates in drug discovery. The study, published Aug. 30 in the journal Science Advances, offers renewed promise when it comes to discovering new drugs.